[A double-blind comparison between mianserin and imipramine (author's transl)]

Area of Science:

• Psychiatry and Clinical Psychology
• Pharmacology and Therapeutics

Background:

• Depression is a prevalent mood disorder requiring effective and well-tolerated treatments.
• Tricyclic antidepressants like imipramine have been standard treatments, but often associated with side effects.
• Mianserin, a tetracyclic antidepressant, offers an alternative with a different pharmacological profile.

Purpose of the Study:

• To compare the antidepressant efficacy of mianserin versus imipramine.
• To evaluate and compare the frequency and severity of side effects between the two treatments.
• To assess treatment outcomes using multiple standardized rating scales.

Main Methods:

• A double-blind, controlled trial involving 54 depressed patients aged 18-65 years.
• Patients received a daily dose of either 60 mg mianserin or 150 mg imipramine for 4 weeks.
• Efficacy was measured using the Hamilton Rating Scale, Beck Depression Inventory, Overall Depression Scale, Brief Psychiatric Rating Scale (BPRS), and a global rating scale.

Main Results:

• No statistically significant differences were found in the antidepressant efficiency between mianserin and imipramine.
• The frequency of reported side effects was significantly lower in the mianserin group compared to the imipramine group.
• Both treatments demonstrated efficacy in reducing depressive symptoms across various assessment scales.

Conclusions:

• Mianserin and imipramine exhibit comparable antidepressant efficacy in patients with depression.
• Mianserin presents a more favorable side effect profile, suggesting potentially better tolerability.
• These findings support mianserin as a viable alternative to imipramine, particularly for patients sensitive to adverse drug reactions.